Face Value Split & Bonus Issue: Anlon Healthcare Limited (AHCL)

Anlon Healthcare Limited has announced a face value split along with a bonus issue as part of a corporate action notified by the exchange. Such initiatives are typically undertaken to improve stock liquidity and make shares more accessible to a broader base of investors.

The corporate action will be effective from April 24, 2026 (Record Date).

Key Details

What this means for investors

For existing shareholders, this corporate action will have a two-step impact:

1. Face Value Split:
   Each share of ₹10 will be subdivided into 5 shares of ₹2 each
2. Bonus Issue (1:1):
   After the split, investors will receive 1 additional share for every 1 share held

While the number of shares in your demat account will increase significantly, the overall value of your investment remains unchanged immediately after the adjustment, as the market price adjusts proportionately.

Illustration

If an investor holds 100 shares of Anlon Healthcare (Face Value ₹10):

• Post Split:
  100 shares → 500 shares (₹2 each)
• Post Bonus (1:1):
  500 shares → 1,000 shares total

The share price will adjust accordingly, so the total investment value remains the same, immediately after the corporate action.Change in the total value of the investment.

Why companies announce such actions

Face value splits and bonus issues are generally undertaken to:

• Improve trading liquidity
• Make shares more affordable for retail investors
• Encourage wider market participation
• Enhance stock accessibility

Lower-priced shares often attract greater investor interest, which can lead to higher trading volumes and improved liquidity.

Conclusion

The combined split and bonus announcement by Anlon Healthcare Limited is aimed at enhancing liquidity and broadening investor participation. While this corporate action does not change the intrinsic value of your investment, it can improve market accessibility and trading activity in the stock.